Skip to search formSkip to main contentSkip to account menu

Non-Hematologic Malignancy

Known as: Non-Hematologic Cancer, nonhematologic cancer 
Cancer that does not begin in the blood or bone marrow.
National Institutes of Health

Related topics

Related topics

3 relations
Malignant NeoplasmsNeoplastic Cellcancer cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma.
We report 5-year follow-up of a multicenter phase 2 study of lenalidomide plus rituximab (LR) as initial treatment of mantle cell… 
Highly Cited
2018
Highly Cited
2018
Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
To determine the risk of a wide range of second malignancies in patients with myeloproliferative neoplasms (MPNs), we conducted a… 
Highly Cited
2017
Highly Cited
2017
Promoting End-of-Life Discussions in Advanced Cancer: Effects of Patient Coaching and Question Prompt Lists.
Purpose To build on results of a cluster randomized controlled trial (RCT) of a combined patient-oncologist intervention to… 
Highly Cited
2016
Highly Cited
2016
Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer: The VOICE Randomized Clinical Trial
Importance Observational studies demonstrate links between patient-centered communication, quality of life (QOL), and aggressive… 
Review
2016
Review
2016
New dimension of glucocorticoids in cancer treatment
2014
2014
A microfluidic model for organ-specific extravasation of circulating tumor cells.
Circulating tumor cells (CTCs) are the principal vehicle for the spread of non-hematologic cancer disease from a primary tumor… 
Highly Cited
2006
Highly Cited
2006
Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
BACKGROUND:  Red blood cell (RBC) alloimmunization is common in transfused patients. Most studies report on the rate of… 
2002
2002
Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological…
Most hematogenous candidiasis originates from endogenous host flora. The impact of clinically prominent Candida colonization on… 
Highly Cited
1994
Highly Cited
1994
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
Background Amphotericin B has long been the standard treatment for candidemia, but its use is complicated by its toxicity. More… 
Highly Cited
1994
Highly Cited
1994
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
BACKGROUND Amphotericin B has long been the standard treatment for candidemia, but its use is complicated by its toxicity. More… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)